Braun Stacey Associates’s Omnicell OMCL Stock Holding History
Bought
Maintained
Sold
Other funds holding OMCL
CS
CCA
ACH
GCM
Braun Stacey Associates's OMCL Position: Q3 2020 in Review
Braun Stacey Associates sold out of Omnicell (OMCL) in Q3 2020, closing a stake of 20,845 shares — an estimated $1.47M sold.
Braun Stacey Associates first reported a position in OMCL in Q4 2013 and held it in 17 quarters. The position peaked at $17.4M in Q2 2019. 304 funds tracked by Wall St. Rank hold OMCL as of Q3 2020.
- Braun Stacey Associates reported no remaining Omnicell position as of Q3 2020 after selling out during the quarter.
- Braun Stacey Associates sold 20,845 Omnicell shares in Q3 2020, an estimated $1.47M.
- Braun Stacey Associates first reported a position in Omnicell in Q4 2013 and held it in 17 quarters.
- Braun Stacey Associates's Omnicell position peaked at $17.4M in Q2 2019.
- 304 funds tracked by Wall St. Rank held Omnicell as of Q3 2020.
Based on Braun Stacey Associates's 13F filing for Q3 2020, filed 27 Oct 2020.